University of Maryland Medical Center Department of Emergency Medicine has completed its participation in a clinical research study called RAMPART, the Rapid Anticonvulsant Medications Prior to Arrival Trial. This nation-wide study has reached its enrollment target and has stopped enrolling patients across the country. RAMPART was an EMS trial designed to study if seizure drug given as a shot in the muscle was just as effective as seizure drug given through an IV into the vein at stopping seizures.
Residents within the communities served by Baltimore City EMS who opted-out of the trial by wearing a "RAMPART Declined" bracelet can now stop wearing this bracelet.
Results from this study will be released to the local public and will also be available on the RAMPART website at rampart.umich.edu after the data has been analyzed.
For more information, contact a member of the RAMPART study team at The University of Maryland 1-800-492-5538.
For patient inquiries, call 1-800-492-5538 or click here to make an appointment.